DENTSPLY SIRONA Inc. (XRAY) Shares Bought by BlueMountain Capital Management LLC
BlueMountain Capital Management LLC increased its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 529.9% in the second quarter, according to its most recent disclosure with the SEC. The firm owned 18,310 shares of the medical instruments supplier’s stock after purchasing an additional 15,403 shares during the period. BlueMountain Capital Management LLC’s holdings in DENTSPLY SIRONA were worth $1,187,000 as of its most recent filing with the SEC.
A number of other institutional investors have also bought and sold shares of the stock. Amalgamated Bank grew its holdings in DENTSPLY SIRONA by 57.5% during the second quarter. Amalgamated Bank now owns 25,452 shares of the medical instruments supplier’s stock worth $1,650,000 after purchasing an additional 9,296 shares during the period. Bahl & Gaynor Inc. grew its holdings in DENTSPLY SIRONA by 1.5% during the second quarter. Bahl & Gaynor Inc. now owns 148,867 shares of the medical instruments supplier’s stock worth $8,594,000 after purchasing an additional 2,191 shares during the period. Comerica Securities Inc. bought a new position in DENTSPLY SIRONA during the second quarter worth about $233,000. Ameriprise Financial Inc. grew its holdings in DENTSPLY SIRONA by 11.8% during the second quarter. Ameriprise Financial Inc. now owns 1,521,172 shares of the medical instruments supplier’s stock worth $98,623,000 after purchasing an additional 160,818 shares during the period. Finally, Teachers Advisors LLC grew its holdings in DENTSPLY SIRONA by 0.5% during the second quarter. Teachers Advisors LLC now owns 342,742 shares of the medical instruments supplier’s stock worth $22,223,000 after purchasing an additional 1,616 shares during the period. Institutional investors and hedge funds own 93.87% of the company’s stock.
Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) opened at 58.65 on Thursday. The firm’s market capitalization is $13.46 billion. The stock has a 50 day moving average of $56.98 and a 200-day moving average of $61.67. DENTSPLY SIRONA Inc. has a 52-week low of $52.54 and a 52-week high of $65.68.
DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.65 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.65. The company had revenue of $992.70 million during the quarter, compared to the consensus estimate of $1 billion. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. DENTSPLY SIRONA’s revenue for the quarter was down 2.9% on a year-over-year basis. During the same period last year, the firm earned $0.76 EPS. Equities analysts expect that DENTSPLY SIRONA Inc. will post $2.68 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 13th. Investors of record on Friday, September 29th will be issued a $0.0875 dividend. This represents a $0.35 annualized dividend and a yield of 0.60%. The ex-dividend date is Thursday, September 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -10.09%.
ILLEGAL ACTIVITY WARNING: “DENTSPLY SIRONA Inc. (XRAY) Shares Bought by BlueMountain Capital Management LLC” was first reported by Daily Political and is the sole property of of Daily Political. If you are reading this article on another site, it was illegally copied and reposted in violation of U.S. and international copyright and trademark legislation. The correct version of this article can be viewed at https://www.dailypolitical.com/2017/09/21/dentsply-sirona-inc-xray-shares-bought-by-bluemountain-capital-management-llc.html.
XRAY has been the subject of a number of research analyst reports. Zacks Investment Research upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $72.00 price objective for the company in a report on Thursday, July 13th. BidaskClub cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Wednesday, July 19th. HC Wainwright initiated coverage on DENTSPLY SIRONA in a report on Tuesday, July 11th. They set a “buy” rating and a $74.00 price objective for the company. Credit Suisse Group restated an “outperform” rating and set a $75.00 price objective (up previously from $67.00) on shares of DENTSPLY SIRONA in a report on Thursday, July 13th. Finally, Jefferies Group LLC reduced their price objective on DENTSPLY SIRONA from $72.00 to $66.00 and set a “buy” rating for the company in a report on Wednesday, August 23rd. Three investment analysts have rated the stock with a sell rating, three have given a hold rating and seven have assigned a buy rating to the company. DENTSPLY SIRONA currently has an average rating of “Hold” and a consensus target price of $65.73.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY).
Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.